Bernard Taverne

ORCID: 0000-0002-3708-5883
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • Healthcare Systems and Practices
  • Viral Infections and Outbreaks Research
  • Migration, Identity, and Health
  • HIV/AIDS Impact and Responses
  • Aging, Elder Care, and Social Issues
  • African Studies and Ethnography
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV, Drug Use, Sexual Risk
  • Health, Medicine and Society
  • Disaster Response and Management
  • Global Maternal and Child Health
  • HIV-related health complications and treatments
  • French Urban and Social Studies
  • COVID-19 epidemiological studies
  • Pharmaceutical Economics and Policy
  • Healthcare Systems and Reforms
  • Vaccine Coverage and Hesitancy
  • Hepatitis B Virus Studies
  • Child Nutrition and Water Access
  • Viral Infections and Vectors
  • Natural Resources and Economic Development
  • Global Security and Public Health
  • Death, Funerary Practices, and Mourning

Agropolis International
2017-2024

Recherches Translationnelles sur le VIH et les Maladies Infectieuses
2012-2024

Institut de Recherche pour le Développement
2015-2024

Inserm
2016-2024

Université de Montpellier
2015-2024

Centre Hospitalier National Universitaire de Fann
2008-2020

Centre Norbert Elias
2015-2016

École des hautes études en sciences sociales
2016

Institut de Recherche pour le Développement
2014

Sub-Regional Fisheries Commission
2014

The 2013-2016 West African Ebola outbreak infected 28,616 people and caused 11,310 deaths by 11 May 2016, across six countries. has also resulted in the largest number of EVD survivors history-over 17,000. Guinea was declared Ebola-free on 1 June 2016. Reports from documented 3814 cases resulting 2544 1270 survivors. face various neuropsychological psycho-affective alterations that have not been fully identified yet. This study aims to document depressive symptoms among adult...

10.1186/s12888-017-1280-8 article EN cc-by BMC Psychiatry 2017-04-04

Cardiovascular risk factors in people on antiretroviral treatment (ART) are poorly documented resource-constrained settings. A cross-sectional study was conducted 2009 to assess prevalence of diabetes and hypertension a sample 242 HIV-infected patients who had initiated ART between 1998 2002 Dakar, Senegal (ANRS 1215 observational cohort). World Health Organization (WHO) criteria were applied diagnose hypertension. Multiple logistic regressions used identify associated with Patients median...

10.5402/2012/621565 article EN ISRN AIDS 2012-12-01

Background: Adherence is one of the main predictors antiretroviral treatment success. A governmental initiative was launched in 1998 for HIV-infected patients Senegal to provide access highly active therapy. Methods: Between August and April 2002, 404 adult were enrolled. measurements, defined as pills taken/pills prescribed, assessed between November 1999 2009 using a pill count along with questionnaire 330 patients. Predictors adherence explored through random-intercept Tobit model latent...

10.1097/qai.0b013e318211b43b article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2011-02-05

10.1007/s13149-016-0510-5 article EN Bulletin de la Société de pathologie exotique 2016-07-25

In Senegal in 2015, an estimated 4800 children were living with HIV, 1200 receiving ARV treatment, of whom half had follow-up care decentralized sites outside Dakar. However, until now no studies have determined the efficacy pediatric treatment settings, even though emergence viral resistance, particularly among Africa, is a well-known phenomenon. This study aimed to assess virological status HIV-infected all facilities help improve access quality care. A cross-sectional epidemiological and...

10.1186/s12887-019-1420-z article EN cc-by BMC Pediatrics 2019-02-05

Abstract Background Longitudinal analyses are needed to better understand long-term Ebola virus disease (EVD) sequelae. We aimed estimate the prevalence, incidence, and duration of sequelae identify risk factors associated with symptom occurrence among EVD survivors in Guinea. Methods followed 802 over 48 months recorded clinical symptoms their start/end dates. Prevalence, were calculated. Risk assessed using an extended Cox model for recurrent events. Results Overall, prevalence incidence...

10.1093/cid/ciab168 article EN cc-by-nc-nd Clinical Infectious Diseases 2021-02-22

Objectives Description and analysis of the Senegalese Antiretroviral Drug Access Initiative (ISAARV), first governmental highly active antiretroviral therapy (HAART) treatment programme in Africa, launched 1998. Methods results ISAARV was initially an experimental project designed to evaluate feasibility, efficacy acceptability HAART African context. It based on four principles: collective definition strategy, with involvement health professionals who would be called execute programme;...

10.1097/00002030-200317003-00013 article EN AIDS 2003-07-01

BackgroundInsufficient long-term data are available on antibody kinetics in survivors of Ebola virus disease (EVD). Likewise, few studies, with very small sample sizes, have investigated cross-reactions between Ebolavirus spp. In this study, we aimed to assess the humoral response and its determinants EVD cross-reactivity antibodies diverse spp.MethodsIn observational, prospective cohort collected blood samples from patients three recruitment sites Guinea included Postebogui assessed IgG...

10.1016/s2666-5247(21)00170-1 article EN cc-by-nc-nd The Lancet Microbe 2021-09-03

Background Bone status in HIV-infected patients on antiretroviral treatment (ART) is poorly documented resource-limited settings. We compared bone mineral density between and control subjects from Dakar, Senegal. Methods A total of 207 (134 women 73 men) an observational cohort Dakar (ANRS 1215) age- sex-matched controls the general population were enrolled. was assessed by quantitative ultrasound (QUS) at calcaneus, alternative to reference method (i.e. dual X-absorptiometry), often not...

10.1371/journal.pone.0031726 article EN cc-by PLoS ONE 2012-02-16

Previous studies show that arthralgia is the most common symptom experienced by Ebola virus disease (EVD) survivors. Nevertheless, specific analyses of rheumatological sequelea are still lacking.The Postebogui study a prospective, multicentre cohort aiming to evaluate long-term outcomes EVD survivors infected during 2014-15 outbreak in Guinea. Of 216 participants enrolled October 2015, 44 patients with arthralgia/myalgia underwent physical examination rheumatologist (the Eborheum cohort)....

10.1093/rheumatology/kex074 article EN Lara D. Veeken 2017-03-15

Résumé. Au Burkina Faso, comme dans d'autres pays d'Afrique de l'Ouest, certains messages d'information contre le sida prétendent qu'il faut combattre la pratique du lévirat parce qu'elle favoriserait diffusion maladie. Sur plan épidémiologique, il peut être démontré que suppression serait sans effet bénéfique sur maladie population. Par contre, l'étude cette institution montre domaine social, ces contribuent à : - stigmatiser les femmes en désignant responsables propagation ; légitimer...

10.3406/sosan.1996.1360 article FR Sciences sociales et santé 1996-01-01

Objectives: In Senegal, the dominant social norm upholds virginity before marriage and edifies abstinence for adolescents as a cardinal moral value. Currently, sex outside of remains socially condemned. The onset adolescent girls born with HIV in Senegal brings up several challenges. Dakar, initiatives, especially through digital applications, are being developed to support these young people. These programs much rarer rural settings. A study conducted 2021 explored how who live Dakar...

10.1177/20499361231159295 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2023-01-01

ObjectivesTo compare virological effectiveness in patients who continued on a virologically successful first-line boosted protease inhibitor (PI)-containing combination antiretroviral therapy (cART) regimen or switched to PI-free cART including efavirenz, nevirapine abacavir.

10.1093/jac/dkr208 article EN Journal of Antimicrobial Chemotherapy 2011-06-01
Coming Soon ...